Phase II study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancer

The purpose of this study was to evaluate the efficacy, assesed as response rate, and toxicity of UFT (Tegafur-Uracil) in combination with oxaliplatin as first-line treatment of advanced colorectal cancer (CRC). In all, 84 patients with recurrent or metastatic CRC with measurable disease were includ...

Descripción completa

Detalles Bibliográficos
Autores principales: Feliu, J, Vicent, J M, García-Girón, C, Constela, M, Fonseca, E, Aparicio, J, Lomas, M, Antón-Aparicio, L, Dorta, F J, Gonzalez-Baron, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410059/
https://www.ncbi.nlm.nih.gov/pubmed/15505621
http://dx.doi.org/10.1038/sj.bjc.6602217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410059/
https://www.ncbi.nlm.nih.gov/pubmed/15505621
http://dx.doi.org/10.1038/sj.bjc.6602217

Ejemplares similares